focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksALM.L Regulatory News (ALM)

  • There is currently no data for ALM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

HawkEye 360 commissions satellite cluster

26 Feb 2019 07:00

RNS Number : 0742R
Allied Minds PLC
26 February 2019
 

HawkEye 360 successfully commissions Pathfinder satellite cluster

 

 

Boston, MA (26 February 2019) - Allied Minds portfolio company, HawkEye 360, announces that it has successfully commissioned the three Pathfinder satellites launched in December 2018. On the back of this important milestone, HawkEye 360 will go to market with a full suite of commercially available RF analytics products over the course of 2019.

In commissioning the formation flying pathfinder satellites, HawkEye 360 becomes the first commercial enterprise to develop the capability to independently detect and geolocate sources of diverse RF signals. Early test results have demonstrated successful geolocation of VHF Channels 16 and 70, EPIRB, and AIS signals as well as identifying marine radar signals. This proprietary source of data enables HawkEye 360 to locate and analyze previously undetected activity, providing new insights for maritime, emergency response, and spectrum analysis applications.

"We are generating an entirely new data source for important commercial, defense, and intelligence applications around the world," said HawkEye 360 Chief Executive Officer John Serafini. "As the first to be delivering this type of commercial data, HawkEye 360 will help our customers make more timely and precise decisions. Our team has shown unbelievable dedication and passion to reach a new milestone in space technology in just a few short years."

In the maritime sector, data gathered by HawkEye 360 can provide visibility for law enforcement into suspicious vessel behavior, giving them better information in their pursuit of illicit activity. Search and rescue efforts can be aided through geolocation of emergency beacons, even when broadcasting incorrect GPS coordinates. HawkEye 360's spectrum analysis can survey usage of RF bands to maximize communication spectrum and avoid interference.

"We are thrilled by the breadth of RF data our Pathfinder satellites are gathering from hundreds of miles above the Earth," said Rob Rainhart, Executive Vice President of Engineering for HawkEye 360. "We've achieved much with our early testing and continue to expand the types of signals we can geolocate. It's exciting to have strong momentum as we prepare to go to market with a full suite of commercially available analytics products over the course of 2019."

The company is using the Pathfinder satellites to perform data verification and strategic demonstrations with select customers. These efforts will inform enhancements to the next cluster of satellites currently under development for launch later this year. This next-generation of satellites will broaden the signal range, on-board-processing, and data capabilities as HawkEye 360 expands the constellation to achieve near persistent global coverage.

 

For more information, please contact:

 

Allied Minds plc

Neil Pizey, Head of Corporate Development

+44 7771 872 922

IR@alliedminds.com

FTI Consulting

Ben Atwell / Brett Pollard

+44 20 3727 1000

 

About HawkEye 360

HawkEye 360 is a Radio Frequency (RF) data analytics company. We operate a first-of-its-kind commercial satellite constellation to identify, process, and geolocate a broad set of RF signals. We extract value from this unique data through proprietary algorithms, fusing it with other sources to create powerful analytical products that solve hard challenges for our global customers. Our products include maritime domain awareness and spectrum mapping and monitoring; our customers include a wide range of commercial, government and international entities. More information about HawkEye 360 can be found at www.he360.com.

 

About Allied Minds

Allied Minds plc is an IP commercialisation company focused on early stage company creation and development within the technology and life science sectors. Allied Minds sources, operates and funds a portfolio of companies to generate long-term value for its investors and stakeholders. Based in Boston, Allied Minds supports its businesses with capital, management, expertise and shared services. For more information, please visit www.alliedminds.com.

 

Allied Minds Forward-Looking Statement

This press release contains statements that are or may be forward-looking statements, including statements that relate to Allied Minds' future prospects, developments and strategies. The forward-looking statements are based on current expectations and are subject to known and unknown risks and uncertainties that could cause actual results, performance and achievements to differ materially from current expectations, including, but not limited to, those risks and uncertainties described in the risk factors included in Allied Minds' regulatory filings. These forward-looking statements are based on assumptions regarding the present and future business strategies of Allied Minds and the environment in which it will operate in the future. Each forward-looking statement speaks only as at the date of this press release. Except as required by law, regulatory requirement, the Listing Rules and the Disclosure Guidance and Transparency Rules, neither Allied Minds nor any other party intends to update or revise these forward-looking statements, whether as a result of new information, future events or otherwise.

 

###

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCSEUEEIFUSESE
Date   Source Headline
31st Jan 20173:55 pmRNSTotal Voting Rights
30th Jan 201712:02 pmRNSPrice Monitoring Extension
3rd Jan 20172:48 pmRNSHolding(s) in Company
3rd Jan 20172:11 pmRNSTotal Voting Rights
13th Dec 20167:00 amRNSFormation of Signature Medical, Inc.
9th Dec 20165:04 pmRNSHolding(s) in Company
7th Dec 20164:34 pmRNSHolding(s) in Company
6th Dec 20165:05 pmRNSHolding(s) in Company
6th Dec 20165:04 pmRNSHolding(s) in Company
2nd Dec 20167:00 amRNSResults of equity placing
1st Dec 20164:50 pmRNSProposed Equity Placing
23rd Nov 20167:00 amRNSHawkEye 360 Raises $11m in Series A Financing
21st Nov 20167:00 amRNSFormation of Vatic Materials, Inc.
18th Nov 20163:15 pmRNSBlock Listing Six Monthly Return
11th Nov 20165:17 pmRNSHolding(s) in Company
24th Oct 20167:00 amRNSPrecision Biopsy Raises $5.0 Million
17th Oct 201612:07 pmRNSSecond Price Monitoring Extn
17th Oct 201612:02 pmRNSPrice Monitoring Extension
29th Sep 20167:00 amRNSAllied Minds & GE Ventures Form Strategic Alliance
8th Sep 201612:02 pmRNSPrice Monitoring Extension
31st Aug 20165:11 pmRNSTotal Voting Rights
25th Aug 20167:00 amRNSHalf-year Report
22nd Aug 20167:00 amRNSAllied Minds Secures $20m Debt Facility from SVB
22nd Aug 20167:00 amRNSAllied Minds' Subsidiary ABLS II Raises $15m
1st Aug 20167:00 amRNSSciFluor Enters Clinical Trial Stage
29th Jul 201610:30 amRNSTotal Voting Rights
13th Jul 201610:02 amRNSDirector/PDMR Shareholding
13th Jul 201610:01 amRNSDirector/PDMR Shareholding
13th Jul 201610:01 amRNSDirector/PDMR Shareholding
13th Jul 201610:00 amRNSDirector/PDMR Shareholding
7th Jul 20167:00 amRNSLong Term Incentive Plan - Listing Application
30th Jun 20167:00 amRNSTotal Voting Rights
22nd Jun 20164:41 pmRNSSecond Price Monitoring Extn
22nd Jun 20164:35 pmRNSPrice Monitoring Extension
14th Jun 20162:38 pmRNSDirector/PDMR Shareholding
13th Jun 20165:18 pmRNSDirector/PDMR Shareholding
31st May 20164:44 pmRNSBlocklisting Six Monthly Return
26th May 20165:23 pmRNSResult of AGM
26th May 20167:00 amRNSAGM Statement
25th May 20167:00 amRNSABLS II Completes Drug Feasibility Programme
13th May 20167:00 amRNSDirector/PDMR Shareholding
10th May 20164:30 pmRNSLong Term Incentive Plan
28th Apr 201612:33 pmRNSHolding(s) in Company
26th Apr 20167:00 amRNSAllied Minds Raises $80m for ABLS Capital
25th Apr 20167:00 amRNSAnnual Financial Report
19th Apr 20167:00 amRNSAppointment of Joint Broker
16th Mar 20167:00 amRNSABLS agrees license with NYU
10th Feb 20164:40 pmRNSSecond Price Monitoring Extn
10th Feb 20164:36 pmRNSPrice Monitoring Extension
9th Feb 20164:40 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.